Clinical trial

A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate

NCT01480388

Study summary

ClinicalTrials.gov

A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Placebo/JNJ-39758979 (300 mg/d) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention JNJ-39758979 (10 mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention JNJ-39758979 (30 mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention JNJ-39758979 (100 mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention JNJ-39758979 (300 mg) Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE2

Conditions

Active Rheumatoid Arthritis; Rheumatoid Arthritisunresolved

Interventions

Placebo/JNJ-39758979 (300 mg/d)DRUG

JNJ-39758979 (10 mg)DRUG

JNJ-39758979 (30 mg)DRUG

JNJ-39758979 (100 mg)DRUG

JNJ-39758979 (300 mg)DRUG

Sponsors & collaborators

Janssen Research & Development, LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01480388 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.